Aptevo Therapeutics Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Aptevo Therapeutics Inc. (APVO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-26
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -0.10%.
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -0.10%, a 112.50% decline from fiscal 2022.
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 0.80%.
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | -0.10% 10-K · filed 2026-03-26 |
| 2023-12-31 | -0.10% 10-K · filed 2025-02-14 |
| 2022-12-31 | 0.80% 10-K · filed 2024-03-05 |
| 2021-12-31 | 0.00% 10-K · filed 2023-03-30 |
| 2020-12-31 | -1.10% 10-K · filed 2022-03-24 |
| 2019-12-31 | -0.70% 10-K · filed 2021-03-31 |
| 2018-12-31 | -0.20% 10-K · filed 2020-03-25 |
| 2017-12-31 | -0.30% 10-K · filed 2019-03-18 |
| 2016-12-31 | -7.40% 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |